Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW: Safety Overview

Metric NIVOLUMAB NIVOLUMAB\RELATLIMAB-RMBW
Total FAERS Reports 87,742 500
Deaths Reported 23,086 120
Death Rate 26.3% 24.0%
Hospitalizations 36,530 147
Average Patient Age 64.2 yrs 64.8 yrs
% Female Patients 34.0% 33.2%
Manufacturer E.R. Squibb & Sons, L.L.C. N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A